SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The $ROSIE project centers around a unique, AI-powered memecoin inspired by "Rosie the Robot," a beloved character known for her role as a caring, motherly robot in popular culture. The purpose of $ROSIE is twofold: entertainment through an interactive AI feature and social impact via charitable donations.  Users can interact with an AI version of Rosie on the project’s website, where they can ask questions and engage in conversations. The utility of $ROSIE goes beyond typical memecoins by enabling users to donate tokens, which will be directed towards charitable causes supporting mothers. Through this initiative, the project combines the viral appeal of meme tokens with meaningful contributions to social causes, while leveraging AI technology to create a novel user experience.

Rosie the Robot

ROSIE CRYPTO is gaining attention, particularly regarding its integration with Phantom Wallet. The community highlights the token's 'early moon' potential and strong momentum, suggesting a possible breakout. Bullish sentiment is building, with many emphasizing it as an opportune entry point.

The SolyCat is a symbol of energy and mystery. Shining like the sun and agile as a feline.  Solycat is here to take over Solana! Inspired by Shiba Inu’s legendary rise on Ethereum, Solycat is the ultimate meme coin designed for Solana’s fast and scalable blockchain.  Our mission is simple: become the top cat of Solana. With bold branding, a vibrant community, and unstoppable momentum, Solycat is ready to dominate. This isn’t just another token—it’s a movement powered by fun, creativity, and the spirit of decentralization.  Join the pride and let’s make history, one paw at a time!

Solycat

Solycat ($SOLYCAT) is trending amid community excitement surrounding its recent listing on Phantom Wallet. Positive sentiment suggests potential gains, with many referring to it as a hidden gem within the Solana ecosystem. The listing appears to be a catalyst for increased attention and discussion.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

$PAW is trending amidst community excitement surrounding its multi-chain ecosystem and ongoing development, including news about new projects launching and validator updates. Community members express bullish sentiment, focusing on the project's potential for growth and interoperability. Discussions also highlight staking and upcoming partnerships.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending due to recent listing news and a surge in interest surrounding its AI agent ecosystem. Community members are actively discussing its potential, the utility of its agents, and possible price targets. The broader context includes the growing excitement around AI-related crypto projects and Base network tokens.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals ($SNDX) is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community debating the likelihood of approval and its potential impact. Some traders point to the drug's existing approval for a related condition and analysts' price targets while others cite concerns about side effects and market manipulation. Discussions also mention potential competition and buyout scenarios.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is gaining attention as traders discuss a potential short squeeze, citing its small float and high insider ownership. Community members are speculating on price targets, with some drawing comparisons to past runners. Bullish sentiment appears to be building, as investors anticipate a strong opening next week.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending as traders discuss recent price volatility and a company statement indicating no known reason for the movement. The community is debating potential dilution, short covering, and the stock's long-term value given its artificial heart technology. Some traders are eyeing potential gains while acknowledging the risks associated with the stock's behavior.

TOSHI

TOSHI is trending as community members discuss its potential for a significant rally, pointing to its strong performance relative to other cryptocurrencies during a recent market dip. Bullish sentiment is fueled by anticipation of exchange listings and the coin's position as the 'face of Base,' with some community members speculating on a possible breakout to new all-time highs. Community buzz highlights the coin's strong support level and growing holder base.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the community debates the stock's future following its recent FDA approval, with some expressing frustration over the share price decline and raising concerns about potential dilution. Others remain optimistic, pointing to the drug's potential, BlackRock's increased stake, and a possible short squeeze. Discussions also involve the company's management and upcoming catalysts.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid is trending as community members debate the company's future amid concerns about production numbers and cash flow. Discussions revolve around the Gravity SUV rollout, potential partnerships, and whether Lucid can meet its production targets. Some traders are attempting to profit from volatility, while others are evaluating the long-term viability of the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rogers Corporation Announces Transition of Board Chair and Plans to Add New Independent Director

Rogers Corporation (NYSE: ROG) (the Company) today announced that Peter Wallace, Chair of the Board of Directors (the Board), has informed the Board of his decision not to stand for re-election at...

Rogers Corporation Schedules Third Quarter 2025 Earnings Call for October 29

Rogers Corporation (NYSE:ROG) (Rogers) plans to announce third quarter 2025 results on October 29, 2025 after market close, which will be followed by a conference call at 5:00 pm ET. The call will be...

Roche's Elecsys pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology

Roche's Elecsys pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology Roche's Elecsys pTau181 becomes the only FDA-cleared blood...

Strength Seen in Ouster (OUST): Can Its 13.4% Jump Turn into More Strength?

Ouster (OUST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Rogers Corp. (ROG) Q2 Earnings Lag Estimates

Rogers Corp. (ROG) delivered earnings and revenue surprises of -32.00% and +2.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Sarepta stock falls after Elevidys fails to get backing by EU regulators

Investing.com --  Sarepta  Therapeutics Inc. (NASDAQ:SRPT) stock declined 13% Friday after European regulators recommended against approving Elevidys, the company’s gene therapy for Duchenne muscular dystrophy.

TTM (TTMI) Surges 5.4%: Is This an Indication of Further Gains?

TTM (TTMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

European pharmaceutical shares edge lower after Trump threatens 200% drug tariff

Investing.com - Shares of European drugmakers slipped on Wednesday after U.S. President Donald Trump said that tariffs of up to 200% on pharmaceutical imports could be coming "very soon."

Deutsche Bank bearish on European pharma stocks into Q2 amid political headwinds

Investing.com -- Deutsche Bank has made several rating and target price adjustments across the European pharmaceuticals space ahead of second-quarter earnings, flagging continued weakness in the sector and potential opportunities in select names.

Roche shares Fall 2% after fatalities halt Elevidys dosing in key patient group

Rogers Corp. engages in the design, development, manufacture, and sale of engineered materials and components for mission critical applications. It operates through the following segments: Advanced Electronics Solutions (AES), Elastomeric Material Solutions (EMS), and Other. The AES segment focuses on the designs, development, manufacture, and sale of circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in electric and hybrid electric vehicles, wireless infrastructure, automotive, telematics and thermal solutions, aerospace and defense, mass transit, clean energy, connected devices, and wired infrastructures. The EMS segment is involved in the designs, development, manufacture, and sale of engineered material solutions for a wide variety of applications and markets. The Other segment consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets. The company was founded by Peter Rogers in 1832 and is headquartered in Chandler, AZ.

Rogers Corp.

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

ROG
Rogers Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ROG News

ROGRogers Corp.